Two New Prior Approval Drug Classes

Effective Feb. 2, 2022 two new drug classes, Evrysdi and Continuous Glucose Monitoring Systems, will be available in the NCTracks Provider Portal. 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

M22021 - R - 2452